Stay updated on NC-6004+Pembrolizumab Combination in Head & Neck Cancer Clinical Trial

Sign up to get notified when there's something new on the NC-6004+Pembrolizumab Combination in Head & Neck Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the NC-6004+Pembrolizumab Combination in Head & Neck Cancer Clinical Trial page

  1. Check
    2 days ago
    No Change Detected
  2. Check
    9 days ago
    Change Detected
    Summary
    No meaningful content changes were detected in the Study Details page for NCT03317327. The information and layout remain the same as in the prior screenshot.
    Difference
    0.5%
    Check dated 2025-11-03T13:48:10.000Z thumbnail image
  3. Check
    17 days ago
    No Change Detected
  4. Check
    38 days ago
    Change Detected
    Summary
    Update includes a prominent operating-status notice and a version upgrade from v3.1.0 to v3.2.0. The core effect is informing users about possible delays and the current open status of the NIH Clinical Center.
    Difference
    4%
    Check dated 2025-10-06T04:27:25.000Z thumbnail image
  5. Check
    45 days ago
    Change Detected
    Summary
    Page updates version from v3.0.2 to v3.1.0 and removes a specific disease resource; otherwise, core content remains unchanged.
    Difference
    0.7%
    Check dated 2025-09-29T01:09:28.000Z thumbnail image
  6. Check
    59 days ago
    Change Detected
    Summary
    The page now shows Revision: v3.0.2 (replacing v3.0.1) and the Back to Top link has been removed.
    Difference
    0.2%
    Check dated 2025-09-14T18:44:21.000Z thumbnail image
  7. Check
    66 days ago
    Change Detected
    Summary
    The web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content.
    Difference
    0.2%
    Check dated 2025-09-07T13:11:22.000Z thumbnail image
  8. Check
    74 days ago
    Change Detected
    Summary
    The web page has undergone significant updates, including the addition of a facility name and location, as well as new resources related to genetic and rare diseases, particularly in the context of head and neck squamous cell carcinoma and radiation therapy. Several previous terms and categories related to cancer treatment have been removed.
    Difference
    4%
    Check dated 2025-08-31T05:37:42.000Z thumbnail image

Stay in the know with updates to NC-6004+Pembrolizumab Combination in Head & Neck Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the NC-6004+Pembrolizumab Combination in Head & Neck Cancer Clinical Trial page.